Literature DB >> 2703258

The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.

D Su1, N Van Rooijen.   

Abstract

The primary antibody response to intravenously administered and liposome-associated human serum albumin (HSA) was studied in mice under conditions where no response could be detected against the non-liposome-associated form of the antigen. The positive response against the antigen, entrapped in and/or exposed on the surfaces of liposomes, thus resulted from the adjuvant action of the liposomes. In mice intravenously injected with dichloromethylene diphosphonate (C12MDP) also entrapped in liposomes, all red pulp macrophages, marginal metallophilic macrophages and marginal zone macrophages had disappeared from the spleen 2 days after administration. Twenty-two days after such a treatment red pulp macrophages and marginal metallophilic macrophages had reappeared, but marginal zone macrophages were still absent. In mice injected with liposome-associated HSA at 2 days after treatment with the C12MDP liposomes, anti-HSA responses were severely depressed, but administration of the liposome-associated antigen 22 days after C12MDP liposomes elicited a normal response. These results point to a role of splenic macrophages in the processing of liposome-associated antigens, but marginal zone macrophages, which are located close to the open ends of the white pulp capillaries and thus are the first macrophages to meet the antigens arriving in the marginal zone are not required.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703258      PMCID: PMC1385238     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response.

Authors:  D Davis; A Davies; G Gregoriadis
Journal:  Immunol Lett       Date:  1987-04       Impact factor: 3.685

2.  Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.

Authors:  D Davis; G Gregoriadis
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

3.  Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens.

Authors:  N van Rooijen; R van Nieuwmegen
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

4.  Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures.

Authors:  U Pick
Journal:  Arch Biochem Biophys       Date:  1981-11       Impact factor: 4.013

5.  Use of liposomes as biodegradable and harmless adjuvants.

Authors:  N van Rooijen; R van Nieuwmegen
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation.

Authors:  P N Shek; B H Sabiston
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

7.  The secondary immune response against liposome associated antigens.

Authors:  N van Rooijen; R van Nieuwmegen; N Kors
Journal:  Immunol Commun       Date:  1981

8.  Association of an albumin antigen with phosphatidylcholine liposomes alters the nature of immunoglobulins produced during the immune response against the antigen.

Authors:  N Van Rooijen; R Van Nieuwmegen
Journal:  Biochim Biophys Acta       Date:  1983-02-22

9.  The role of macrophages in promoting the antibody response mediated by liposome-associated protein antigens.

Authors:  P N Shek; S Lukovich
Journal:  Immunol Lett       Date:  1982       Impact factor: 3.685

10.  Immune response mediated by liposome-associated protein antigens. I. Potentiation of the plaque-forming cell response.

Authors:  P N Shek; B H Sabiston
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

View more
  10 in total

1.  B cells do not present antigen covalently linked to microspheres.

Authors:  A Galelli; B Charlot; E Dériaud; C Leclerc
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

2.  Immunity Evaluation of an Experimental Designed Nanoliposomal Vaccine Containing FMDV Immunodominant Peptides.

Authors:  L Heshmati; S M Rezayat; R Madani; T Emami; M R Jafari; F Golchinfar; M Kazemi; S M Azimi Dezfouli
Journal:  Arch Razi Inst       Date:  2021-11-30

3.  The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies.

Authors:  J M Brewer; J Richmond; J Alexander
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

5.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 6.  Versatile cell ablation tools and their applications to study loss of cell functions.

Authors:  Fengming Liu; Shen Dai; Dechun Feng; Xiao Peng; Zhongnan Qin; Alison C Kearns; Wenfei Huang; Yong Chen; Süleyman Ergün; Hong Wang; Jay Rappaport; Elizabeth C Bryda; Anand Chandrasekhar; Bertal Aktas; Hongzhen Hu; Sulie L Chang; Bin Gao; Xuebin Qin
Journal:  Cell Mol Life Sci       Date:  2019-07-29       Impact factor: 9.261

7.  Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice.

Authors:  Bin Feng; Ping Jiao; Yaohui Nie; Thomas Kim; Dale Jun; Nico van Rooijen; Zaiqing Yang; Haiyan Xu
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

8.  Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.

Authors:  S Nair; F Zhou; R Reddy; L Huang; B T Rouse
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

9.  Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.

Authors:  Amrita Das; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

Review 10.  Distinct Immunologic Properties of Soluble Versus Particulate Antigens.

Authors:  Clifford M Snapper
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.